Patents by Inventor Seok-Beom YONG

Seok-Beom YONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DUAL-TARGETING LIPID-POLYMER HYBRID NANOPARTICLES
    Publication number: 20210379197
    Abstract: The present invention relates to dual-targeting lipid-polymer hybrid nanoparticles (T-hNPs) comprising a polymer core comprising a heme oxygenase 1 inhibitor and a lipid membrane (shell) comprising a targeting moiety, a kit for preparing the dual-targeting lipid-polymer hybrid nanoparticles, a pharmaceutical composition comprising the dual-targeting lipid-polymer hybrid nanoparticles as an active ingredient, and a method of preventing or treating cancer comprising administering the pharmaceutical composition to a subject in need thereof.
    Type: Application
    Filed: April 12, 2021
    Publication date: December 9, 2021
    Applicant: IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY)
    Inventors: Yong-Hee KIM, Seok-Beom YONG, Jee Young CHUNG, Seong Su KIM, Jae Hyun KIM, Se Hee RA
  • Visceral adipose tissue macrophage-targeted gene/carrier complex for preventing or treating obesity-induced type II diabetes
    Patent number: 10889819
    Abstract: The present invention relates to a visceral adipose tissue macrophage-targeted non-viral gene/carrier complex for preventing and treating obesity-induced type II diabetes. More specifically, the gene/carrier complex according to the present invention delivers a therapeutic gene in a stable manner in a case of being injected into the body with the visceral adipose tissue macrophages being targeted, and thus exhibits an excellent inhibitory effect against TACE, which allows the gene/carrier complex to be applied for prevention or treatment of obesity-induced type II diabetes.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: January 12, 2021
    Inventors: Yong-Hee Kim, Yoon Sung Song, Seok-Beom Yong
  • VISCERAL ADIPOSE TISSUE MACROPHAGE-TARGETED GENE/CARRIER COMPLEX FOR PREVENTING OR TREATING OBESITY-INDUCED TYPE II DIABETES
    Publication number: 20190300886
    Abstract: The present invention relates to a visceral adipose tissue macrophage-targeted non-viral gene/carrier complex for preventing and treating obesity-induced type II diabetes. More specifically, the gene/carrier complex according to the present invention delivers a therapeutic gene in a stable manner in a case of being injected into the body with the visceral adipose tissue macrophages being targeted, and thus exhibits an excellent inhibitory effect against TACE, which allows the gene/carrier complex to be applied for prevention or treatment of obesity-induced type II diabetes.
    Type: Application
    Filed: March 29, 2019
    Publication date: October 3, 2019
    Inventors: Yong-Hee KIM, Yoon Sung SONG, Seok-Beom YONG